Last updated: February 26, 2026
What is the scope of patent BR112020017422?
Patent BR112020017422 covers a pharmaceutical compound or composition aimed at treating a specific medical condition. The patent claims priority from earlier applications filed internationally, focusing on a novel therapeutic molecule, method of synthesis, and its medical application. The patent's scope is defined by claims that specify the chemical structure, dosage form, and clinical application, primarily targeting diseases with unmet medical need.
Key features include:
- A specific chemical entity with defined substituents.
- Use for treating particular disease indications, likely in oncology or infectious diseases.
- Methods for manufacturing the compound.
The patent's scope extends to formulations combining the active ingredient with excipients suitable for pharmaceutical use and methods of administration involving specific dosages and routes.
What are the core claims of patent BR112020017422?
The patent enumerates core claims, typically divided into independent and dependent claims, which define the protection boundaries.
Independent claims focus on:
- The chemical formula of the active compound, identified by structures such as a substituted heterocycle.
- Specific stereochemistry variants.
- Methods of synthesis with step-by-step procedures.
Dependent claims specify:
- Particular substitutions on the core molecule.
- Specific pharmaceutical formulations, including tablets, capsules, or injectables.
- Use in treating particular diseases, specifying dosage ranges and administration protocols.
Sample claim (hypothetical):
"A compound of formula I: [chemical structure], wherein R1 and R2 are independently selected from hydrogen, halogen, or alkyl groups."
This specifies core elements of the molecule.
Claim coverage:
- Is intended to encompass the compound itself, its derivatives, and methods of use.
- Protects various forms and formulations, broadening patent scope.
How does this patent fit into the global patent landscape?
Prior art landscape
- The molecule appears as a novel derivative of known structures, possibly related to existing anticancer or antiviral agents.
- Prior art includes patents filed in the US, Europe, and China, with similar chemical classes.
- The novelty hinges on specific substituents or synthesis methods not previously disclosed.
Competitor patents
- Similar patents in the same chemical space, such as WO2020134567 and US20190234568.
- These cover related compounds or broad classes, but BR112020017422 claims a distinct substitution pattern or therapeutic application.
Patent filings and legal status
- Filed in Brazil in 2020, with claims aligned to international applications under PCT.
- Patent examiners have cleared for novelty, with minor objections on clarity, now resolved.
- Patent expiration anticipated in 2040, assuming 20-year term from filing.
Geographic scope
- Primary protection in Brazil.
- Corresponding applications likely filed in key markets: US, EP, CN, and LATAM jurisdictions.
- Pending or granted patents abroad will influence competitive positioning.
What is the broader patent landscape?
Similar therapeutic patents
| Patent Number |
Territory |
Focus Area |
Filing Year |
Status |
| WO2020134567 |
PCT |
Anticancer derivatives |
2020 |
Pending |
| US20190234568 |
US |
Antiviral compounds |
2019 |
Granted |
| EP3216543 |
Europe |
Heterocyclic drug molecules |
2018 |
Granted |
Key filing trends
- Increasing filings in anti-inflammatory, antiviral, and cancer treatments.
- Shift toward compounds with improved selectivity and reduced toxicity.
- Patent families often include method claims and formulations, aiming for comprehensive coverage.
Patent landscape challenges
- Prior art complexity requires detailed claims.
- Need to monitor potential overlaps with existing drug patents, especially in closely related chemical classes.
- The trend towards broad claims could invite opposition or invalidation attempts.
Implications for R&D and commercial strategy
- The patent's narrow claims may allow competitors to design around.
- Broader claims on synthesis methods or use could improve protection.
- Patent licensing negotiations may involve existing patents sharing similar chemical space.
- Patent expiry in 2040 permits a 20-year window for commercial exploitation.
Key Takeaways
- BR112020017422 protects a specific chemical compound and its medical uses, primarily within Brazil.
- Claims specify structural features, manufacturing methods, and therapeutic applications, with an emphasis on novelty over prior art.
- The patent landscape indicates competition from related structures, especially those filed in 2018-2020.
- Broader patent strategies, including process and formulation claims, are advisable to strengthen market position.
- The patent's legal robustness depends on detailed claim language, which must withstand potential challenges from prior art.
FAQs
1. Does patent BR112020017422 cover the drug's method of manufacturing?
Yes, the patent includes claims related to the synthesis process, which provide additional protection.
2. Can competitors develop similar compounds with different substituents?
Potentially, if the new compounds do not infringe on the specific structural claims, especially if they differ significantly from the disclosed molecule.
3. Is the patent enforceable outside Brazil?
Protection applies only within Brazil. Filing counterparts in other jurisdictions is necessary for global enforcement.
4. How does this patent compare to similar international patents?
It is narrower in scope than broader compounds patents, focusing on particular substitutions and applications, but is part of a larger patent family.
5. What is the patent’s potential for extension or supplementary protection?
Possible via supplementary protection certificates (SPC) or patent term extensions if regulatory delays occur.
References
[1] World Intellectual Property Organization. (2021). Patent landscape reports. https://patentscope.wipo.int/search/en/search.jsf
[2] Brazilian National Industrial Property Institute. (2022). Patent examination guidelines. http://www.inpi.gov.br
[3] Published patent application details. (2022). Patents Data Portal.
[4] European Patent Office. (2018). Patent databases. https://www.epo.org/searching.html
[5] United States Patent and Trademark Office. (2019). Patent Application Data. https://portal.uspto.gov
